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Correlation of Minimal Luminal Diameter and the
Decrease in Ischemic Response at Successive
Occlusions During PTCA
Advanced Age Does not Diminish the Results of
PTCA for Acute Ischemic Syndromes
Lesion # pts TECH ANGlO CLiN
LAD 23 57 (37, 77) 91 (79,100) 91 (79, 100)
RCA 30 63 (46, 80) 100 (88, 1DO) 100 (88, 100)
CIRC 22 82 (66, 98) 100 (85,1001 100 185, 100)
LMAIN 1 100 (2.5,1001 100 (25, 100) 100 (2.5, 100)
ALL 76 68 (58,781 97 (93,1001 97 (93,100)
TECH failures included: inability to cross &dilate in 01 pts, inability to toler-
ate 7-10 min dilatation in 16 pts, and use of autoperfusion balloon or stents
in 9 pts. CLiN failures included bypass in 2 pts (no Q-waves or deaths). Thus,
this pilot experience with PTCA of class C lesions using long duration, slow
oscillating inflation of long balloons suggests a randomized trial of "'ong
long" PTCA vs. more expensive techniques is warranted.
It is still matter of discussion, whether improved tolerance to ischemia at
successive balloon inflations (BI) reflects preconditioning or recruitment of
collaterals. The amount of collaterals in patients (pat) with stable angina de-
pends on the severity of the stenosis prior to PTCA. Therefore we studied the
ischemic response to serial BI in 21 patients (pat) with high-grade (>85%) (A)
in comparison to 16 pat with moderate stenoses of <70% (B). All pat had a
single vessel disease (LAD: n = 27; RCA: n = 10), normal ejection fraction
and no visible collaterals. PTCA consisted of 2 BI of 120 sec duration with
an interval of 5 minutes. Ischemia was assessed on chest pain {angina score
(ASI from 0-5), ST-elevation (mm), raise in pulmonary artery (PAP) (mmHgl
and drop in mean aortic pressure IMAP) ImmHg).
Results:
Advanced age has been recognized as adversely influencing the outcome
of coronary revascularization procedures. To determine the validity of this
relationship for patients (pts) with acute ischemic syndromes treated with
contemporary medical therapy, the outcomes of 444 pts who had PTCA per-
formed in TIMIIIIB were analyzed. Each pt received aspirin, heparin and an-
tianginal therapy.
with a target duration of 7-1 amin supported by Fluosol-DA (Alpha) perfusion.
Endpoints were: technical success (TECH): ability to reach, cross &dilate for
> 7 min; angiographic success (ANGlO): >20% reduction & <50% residual
stenosis; clinical success (CLlN): no Q-wave MI, bypass or death prior to
discharge. Results, as % (95% C.I.) were:
*p < 0.05, **p < 0.01 (baseline vs. 120 sec inflation)
Conclusion: The decrease in ischemia at successive 81 is dependent on
the severity of the stenosis. We conclude that this is due to recruitable collat-
erals and does not reflect ischemic preconditioning which would have been
expected to occur in all patients.
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1.BI 2.81
control 120 sec control 120 sec
A 1>90%)
PAP 15 ± 3 27 ± 6* 14 ± 4 19± 5
MAP 98 ± 12 94 ± 15 101 ± 9 95 ± 10
ST I 4.5 ± 2.2** I 2.4 ± 1.5*
AS 0 2.8 ± 0.6** 0 1.7±05*
B«70%1
PAP 16± 4 30 ± 4* 18 ± 5 31 ± 7*
MAP 94 ± 14 92 ± 16 95 ± 12 91 ± 8
ST I 5.5 ± 1.8** I 5.4 ± 2.2**
AS 0 3.9 ± 1.1** 0 4.0±1.1**
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Out-Patient Coronary Angioplasty is Safe and
Cost-Effective
Differential Sizing for Balloon Angloplasty:
Preliminary Results Using a New "Focal"
Balloon with an Expanding Central Section
William D. Knopf, Christopher U. Cates, Nicholas J. Lembo, Caryn Bernstein,
Robbie Moye. Atlanta CardiologV Group, Atlanta, GA
One of the major determinants of costs in healthcare is patient length of stay.
To determine if transluminal coronary angioplasty (TCA) can be performed
safely as an outpatient, 64 patients were randomized to a 9 hour stay (32) vs
an overnight stay (34). There was no statistical difference in the two groups
with regard to risk factors, age, previous TCA, CABG, MI or LVEF. Patients
in both groups had >80% class III or IV angina. There was no difference
in vessels dilated. 46 lesions were dilated in the inpatient group lip) vs 36
lesions in the outpatient group (op) (p = ns). Average balloons/lesion was
1.2 (ip) vs 1.2 (op) (p = ns).
There was no statistical difference in complications between the two
groups. One patient in the ip had acute closure resolved by coronary stent-
ing. However, this occurred prior to sheath removal.
All patients had follow-up at 24 hours and 7 days. One patient had suba-
cute closure 48 hours post procedure at home which resolved by redo TCA.
Patient satisfaction surveys indicate 94% patients and families prefer to go
home the same day as TCA despite an average distance to home of 83 miles.
Summary: Outpatient TCA can be performed safely in select patients with
high patient satisfaction, low patient complications and lower cost by reduc-
ing over all length of stay.
The majority of lesions treated by conventional balloon angioplasty (PTCA)
are focal and less than 10 mm in length. We sought to develop a balloon
which could deliver dilating force to the stenosis in a "focal" manner and
potentially decrease the chances of proximal and distal vessel dissection due
to overexpansion. The CAT balloon (CVD, Irvine, CAl uses variably compliant
material to maintain the proximal and distal 5 mm ends of the balloon at
a constant diameter while allowing the central 10 mm "focal" segment to
expand above nominal diameter at higher pressures. The additional central
diameter achievable is approximately 0.7 mm at 16 atm. A prototype 2.5 mm
(nominal) balloon was used in 30 lesions (23 pts). Success was achieved in all
but 1 case (no balloon would cross). In 3 cases, predilation with a <2.0 mm
balloon was required. In two lesions a larger balloon was subsequently used.
Quantitative analysis was available for 15 lesions. Diameter stenosis was
reduced from 65 ± 15% to 23 ± 14%. There was one type A dissection and
no complications. Initial inflation pressures averaged 6.0 ± 1.4 atm and final
pressures 11.3 ± 2.7 atm. QCA measured balloon diameters over a range of
pressures from 3 to 16 atm showed progressive relative enlargement of the
center section with increased pressures Ir = 0.521. At pressures <10 atm the
balloon center was 0.11 mm (5.6%1 larger than the ends while at pressures
~ 10 atm, the center was 0.44 mm 120.8%) larger (range 0.06 to 0.96 mm).
Conclusion: In this pilot series, the CATfocal balloon with a central expand-
ing section was effectively used to dilate coronary lesions without complica-
tions and with a high success rate. A randomized trial is planned to determine
if this design has advantages over standard balloon catheters.
82% at 4 Atm. In the wire facilitated angioplasty group the final diameter
stenosis was 21 % vs. 29% in the control group (p = 0.001) with a device ef-
ficiency IEFFI (final minimal lumen diameter + maximum balloon size) of 0.76
vs. 0.60 for the controls (p = 0.005). Conclusion: The use of a guidewire ex-
ternal to the balloon increases pressure transmitted to the lesion, improves
distensibility and lowers lesion yielding pressure. Longitudinal force focused
PTCA has the potential to improve acute lumen dimensions, prevent spiral
dissections and enhance device efficiency.
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Revascularization of class C coronary lesions with expensive technologies
or surgery is based on poor acute results using 20 mm balloons. Longer bal-
loons and prolonged, slow oscillating inflations might reduce shear forces. To
test this, PTCA of class C lesions was attempted in 76 pts. using 40 mm Co-
bra POC8 (Scimed) balloons inflated with oscillation increasing 1-2 atm/min,
